Page 97 - University of Pretoria RESEARCH OUTPUTS 2016

Christoforou A, Mulvey C, Breckels L, Geladaki A, Hurrell T, Hayward P, Naake T, Gatto L, Viner R, Arias A, and Lilley K. 2016. A draft map of the mouse pluripotent stem cell spatial proteome. In Nature Communications, 7, pp 1-12. http://hdl.handle.net/2263/51799.
Cordier W, Steenkamp V, and Rashed K. 2016. Antioxidant, antimicrobial properties and acetylcholinesterase inhibitory capacity of Alnus rugosa leaves and its phytochemical analysis. In Pharma Research, 14, pp 64-72.
Cordier W, Steenkamp V, and Rashed K. 2016. An evaluation of antioxidant, anticholinesterase and antimicrobial activities of Liquidambar styraci ua L. leaves. In Pharma Research, 14, pp 57-63.
Curtin F, Porchet HC, Glanzman R, Schneble H, Vidal V, Audoli-Inthavong M, Lambert E, and Hartung H. 2016. A placebo randomized controlled study to test the e cacy and safety of GNbAC1, a monoclonal antibody for the treatment of multiple sclerosis – Rationale and design. In Multiple Sclerosis and Related Disorders, 9, pp 95-100. Elsevier.
Curtin F, Vidal V, Bernard C, Kromminga A, Lang A, and Porchet HC. 2016. Serum pharmacokinetics and cerebrospinal uid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study. In mAbs, 8(5), pp 854-860.
Dodgen TM, Labuschagne C, van Schalkwyk A, Ste ens FE, Gaedigk A, Cromarty AD, Alessandrini M, and Pepper MS. 2016. Pharmacogenetic comparison of CYP2D6 predictive and measured phenotypes in a South African cohort. In Pharmacogenomics Journal, 16(6), pp 566-572.
Gree OBW. 2016. The pharmacotherapy of low back pain. In SA Pharmaceutical Journal, 83(5), pp 18-22.
http://hdl.handle.net/2263/56227.
Liebenberg J, du ToitPrinsloo L, Steenkamp V, and Saayman G. 2016. Fatalities involving illicit drug use in Pretoria, South Africa, for the period 2003-2012. In SAMJ South African Medical Journal, 106(10), pp 1051-1055.
Marais A. 2016. Hypercholesterolaemia: from inauspicious to appropriate to detrimental. In SA Pharmaceutical Journal, 83(1), pp 30-32.
Marais A. 2016. The allergic eye. In South African Family Practice, 58, pp 6-10.
Marais A. 2016. Additional considerations for gastro-oesophageal re ux disease. In South African Family Practice, 58(1), pp 27-30.
http://hdl.handle.net/2263/52777.
Marais A. 2016. The pharmacological management of obesity. In South African Family Practice, 58(4), pp 16-21.
Marais A. 2016. The pharmacological management of erectile dysfunction – Update 2016. In South African Family Practice, 58(4),
pp 10-14. http://hdl.handle.net/2263/56678.
Mer M, Snyman JS, Medlen (Jansen van Rensburg) CE, van Tonder J, and Laurens I. 2016. A prospective, observational study comparing the PK/PD relationships of generic Meropenem (Mercide R) to the innovator brand in critically ill patients. In Clinical Pharmacology: Advances and Applications, 8, pp 191-198.
Mohamed K, and Steenkamp V. 2016. Application of a LC–MS/MS method developed for the determination of p‐phenylenediamine, N‐acetyl‐p‐ phenylenediamine and N,N‐diacetyl‐p‐phenylenediamine in human urine specimens. In Biomedical Chromatography, 30, pp 1922-1927.
Muntingh GL. 2016. A summary overview of the new, direct, target-speci c oral anticoagulants. In South African Family Practice, 58(4), pp 22-25.
Muntingh GL. 2016. Vitamin D - the vitamin hormone. In South African Family Practice, 58(3), pp 32-36.
Muntingh GL. 2016. “Alpha-1, are you in? (C)harlie (O)scar (P)appa (D)elta, over!”. In South African Family Practice, 58(1), pp 19-26.
UP Research Outputs 2016 | 95